Nobel Mini Symposium - Frontiers in Medicine

Caenorhabditis elegans and

Disease Gene Discovery

Monday, 10. March 2003, Nobel Forum, Nobelv. 1

Karolinska Institutet, Solna Campus, Stockholm

Organizers: Ana Vaz Gomes, Thomas Bürglin, Peter Swoboda, Rune Toftgård
 

  9:00-9:10 Welcoming remarks: Hans Wigzell, President of the Karolinska Institutet

  9:10-9:50 Genome wide RNAi screening
                Julie Ahringer, Wellcome Trust/Cancer Research UK, Cambridge, UK

  9:50-10:20 Ras/MAP kinase signaling and the Mediator complex
                  Simon Tuck, UCMP, Umeå University, Umeå, Sweden

10:20-10:50 Coffee

10:50-11:20 Smelling and tasting in worms and diseases thereof
                  Peter Swoboda, Karolinska Institutet & Södertörns Högskola, Sweden

11:20-12:00 Bacillus thuringiensis toxin and C. elegans: A crystalline approach to host-pathogen interactions
                  Raffi Aroian, Cell and Developmental Biology, UC, La Jolla, CA, USA

12.00-12:30 The C. elegans Forkhead gene fkh-3 has a function in the Twist pathway
                  Marika Hellqvist-Greberg, Cell and Molecular Biology, Göteborg University, Göteborg, Sweden

12:30-13:40 Lunch is provided at Nobel Forum for a maximum of 65 persons

Please note that lunch is provided for the speakers, C. elegans researchers, and invited guests. Some additional places are available on a "first come first served-basis" upon registration on arrival at Nobel Forum (sign up at the Reception). 13:40-14:10 The dopaminergic system of C. elegans: druggable targets of human therapeutics.
                   Garry Wong, A.I. Virtanen Institute, Kuopio, Finland

14:10-14:50 Genetic analysis of huntingtin polyglutamine toxicity in the C. elegans nervous system
                  Anne Hart, Massachusetts General Hospital, Charlestown, MA, USA

14:50-15:20 Transcriptional control of nervous system development
                  Thomas Bürglin, Karolinska Institutet & Södertörns Högskola, Sweden

15:20-15:50 coffee

15:50-16:30 Peptides, presenilins and Parkinson
                  Ralf Baumeister, ABI, Molekulare Neurogenetik, Munich, Germany

16:30-17:00 Can novel genes in C. elegans lead us to novel human disease genes?
                  Ana Vaz Gomes, CGB, Karolinska Institutet, Sweden

17:00-17:10 Concluding remarks: Rune Toftgård
 

                                   contact: Ana.Vaz.Gomes@cgb.ki.se, Thomas.Burglin@biosci.ki.se, Peter.Swoboda@biosci.ki.se